Imaging in pelvic exenteration-a multidisciplinary practice guide from the ESGAR-SAR-ESUR-PelvEx collaborative group.
CT
Cancer
MRI
PET/CT
Pelvic exenteration
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
25 Aug 2024
25 Aug 2024
Historique:
received:
08
02
2024
accepted:
16
06
2024
revised:
04
05
2024
medline:
26
8
2024
pubmed:
26
8
2024
entrez:
24
8
2024
Statut:
aheadofprint
Résumé
Pelvic exenteration (PE) is a radical surgical approach designed for the curative treatment of advanced pelvic malignancies, requiring en-bloc resection of multiple pelvic organs. While the procedure is radical, it has shown promise in enhancing long-term survival and is now comparable in surgical mortality to elective resections for primary pelvic cancers. Imaging plays a crucial role in preoperative planning, with MRI, CT, and PET/CT being pivotal in assessing the extent of cancer and formulating a surgical roadmap. This paper presents clinical practice guidelines for imaging in the context of PE, developed jointly by ESGAR, SAR, ESUR, and the PelvEx Collaborative. These guidelines aim to standardize imaging protocols and reporting to improve the preoperative assessment and facilitate decision-making in the multidisciplinary treatment of pelvic cancers. Our recommendations underscore the importance of a multidisciplinary approach and the need for clear and precise imaging reports to optimize patient care. CLINICAL RELEVANCE STATEMENT: Our recommendations underscore the importance of a multidisciplinary approach and the need for clear and precise imaging reports to optimize patient care. KEY POINTS: MRI is mandatory for local staging in pelvic exenteration. Structured reporting (using the template provided in this guide) is recommended. Multidisciplinary review of imaging is critical for surgical planning.
Identifiants
pubmed: 39181949
doi: 10.1007/s00330-024-10940-z
pii: 10.1007/s00330-024-10940-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : HORIZON EUROPE European Research Council
ID : 101077710
Informations de copyright
© 2024. The Author(s), under exclusive licence to European Society of Radiology.
Références
Egger EK, Liesenfeld H, Stope MB et al (2021) Pelvic exenteration in advanced gynecologic malignancies—who will benefit? Anticancer Res 41:3037–3043
doi: 10.21873/anticanres.15086
pubmed: 34083295
Gould LE, Pring ET, Drami I et al (2022) A systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer. Int J Surg 104:106738
doi: 10.1016/j.ijsu.2022.106738
pubmed: 35781038
PelvEx C (2019) Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer. BJS Open 3:516–520
doi: 10.1002/bjs5.50153
PelvEx C (2023) A review of functional and surgical outcomes of gynaecological reconstruction in the context of pelvic exenteration. Surg Oncol 52:101996
PelvExCollaborative (2019) Pelvic exenteration for advanced nonrectal pelvic malignancy. Ann Surg 270:899–905
doi: 10.1097/SLA.0000000000003533
Causa Andrieu PI, Woo S, Rios-Doria E, Sonoda Y, Ghafoor S (2021) The role of imaging in pelvic exenteration for gynecological cancers. Br J Radiol 94:20201460
doi: 10.1259/bjr.20201460
pubmed: 33960814
pmcid: 9327756
Popovich MJ, Hricak H, Sugimura K, Stern JL (1993) The role of MR imaging in determining surgical eligibility for pelvic exenteration. AJR Am J Roentgenol 160:525–531
doi: 10.2214/ajr.160.3.8430546
pubmed: 8430546
Donati OF, Lakhman Y, Sala E et al (2013) Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration. Eur Radiol 23:2906–2915
doi: 10.1007/s00330-013-2875-1
pubmed: 23652852
Lakhman Y, Nougaret S, Micco M et al (2015) Role of MR imaging and FDG PET/CT in selection and follow-up of patients treated with pelvic exenteration for gynecologic malignancies. Radiographics 35:1295–1313
doi: 10.1148/rg.2015140313
pubmed: 26172364
Nougaret S, Nikolovski I, Paroder V et al (2019) MRI of tumors and tumor mimics in the female pelvis: anatomic pelvic space-based approach. Radiographics 39:1205–1229
doi: 10.1148/rg.2019180173
pubmed: 31283453
Kim SR, Lee YY, Brar H et al (2019) Utility of 18F-FDG-PET/CT imaging in patients with recurrent gynecological malignancies prior to pelvic exenteration. Int J Gynecol Cancer. https://doi.org/10.1136/ijgc-2018-000091
Corr A, Fletcher J, Jenkins JT, Miskovic D (2022) Image-guided pelvic exenteration-preoperative and intraoperative strategies. Eur J Surg Oncol 48:2263–2276
doi: 10.1016/j.ejso.2022.08.002
pubmed: 36243647
Moolenaar LR, van Rangelrooij LE, van Poelgeest MIE et al (2023) Clinical outcomes of pelvic exenteration for gynecologic malignancies. Gynecol Oncol 171:114–120
doi: 10.1016/j.ygyno.2023.02.010
pubmed: 36870097
Chiantera V, Rossi M, De Iaco P et al (2014) Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. Int J Gynecol Cancer 24:916–922
doi: 10.1097/IGC.0b013e3182a80aec
pubmed: 24442006
Koh CE, Brown KGM, Steffens D, Young J, Salkeld G, Solomon MJ (2022) What constitutes a clear margin in patients with locally recurrent rectal cancer undergoing pelvic exenteration? Ann Surg 275:157–165
doi: 10.1097/SLA.0000000000003834
pubmed: 32068551
Simillis C, Baird DL, Kontovounisios C et al (2017) A systematic review to assess resection margin status after abdominoperineal excision and pelvic exenteration for rectal cancer. Ann Surg 265:291–299
doi: 10.1097/SLA.0000000000001963
pubmed: 27537531
Sbarra M, Micco M, Corvino M et al (2019) CT findings after pelvic exenteration: review of normal appearances and most common complications. Radiol Med 124:693–703
doi: 10.1007/s11547-019-01009-9
pubmed: 30806919
Tortorella L, Marco C, Loverro M et al (2023) Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: a large single-institution experience. J Gynecol Oncol. https://doi.org/10.3802/jgo.2024.35.e4
van Ramshorst GH, Young JM, Solomon MJ (2021) Reply to comment on, “complications and impact on quality of life of vertical rectus abdominis myocutaneous flaps for reconstruction in pelvic exenteration surgery”. Dis Colon Rectum 64:e100–e101
doi: 10.1097/DCR.0000000000001992
pubmed: 33625051
Austin KK, Solomon MJ (2009) Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement. Dis Colon Rectum 52:1223–1233
doi: 10.1007/DCR.0b013e3181a73f48
pubmed: 19571697
Austin KKS, Brown KGM, Solomon MJ (2024) En bloc lateral pelvic compartment excision during pelvic exenteration: video vignette. Br J Surg 111:znad407
Solomon MJ, Alahmadi R, Lee PJ, Austin KKS (2022) En bloc partial pubic bone excision with complete soft tissue pelvic exenteration. Br J Surg 109:640–641
doi: 10.1093/bjs/znac122
pubmed: 35485605
Solomon MJ, Austin KK, Masya L, Lee P (2015) Pubic bone excision and perineal urethrectomy for radical anterior compartment excision during pelvic exenteration. Dis Colon Rectum 58:1114–1119
doi: 10.1097/DCR.0000000000000479
pubmed: 26445189
Brown KGM, McBride KE, Anderson T, Solomon MJ (2023) Delivering complex surgical services: lessons learned from the evolution of a specialised pelvic exenteration centre. Aust Health Rev 47:735–740
doi: 10.1071/AH23186
pubmed: 38029447
Landoni F, Zanagnolo V, Rosenberg PG et al (2013) Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience. Gynecol Oncol 130:69–74
doi: 10.1016/j.ygyno.2013.02.038
pubmed: 23474343
Luna-Perez P, Rodriguez DF, Flores D, Delgado S, Labastida S (1995) Morbidity and mortality following preoperative radiation therapy and total pelvic exenteration for primary rectal adenocarcinoma. Surg Oncol 4:295–301
doi: 10.1016/S0960-7404(10)80041-6
pubmed: 8809951
PelvEx C (2019) Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration. Ann Surg 269:315–321
doi: 10.1097/SLA.0000000000002528
Husain A, Akhurst T, Larson S, Alektiar K, Barakat RR, Chi DS (2007) A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration. Gynecol Oncol 106:177–180
doi: 10.1016/j.ygyno.2007.03.018
pubmed: 17477959
Chew MH, Brown WE, Masya L, Harrison JD, Myers E, Solomon MJ (2013) Clinical, MRI, and PET-CT criteria used by surgeons to determine suitability for pelvic exenteration surgery for recurrent rectal cancers: a Delphi study. Dis Colon Rectum 56:717–725
doi: 10.1097/DCR.0b013e3182812bec
pubmed: 23652745
Burger IA, Vargas HA, Donati OF et al (2013) The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration. Gynecol Oncol 129:586–592
doi: 10.1016/j.ygyno.2013.01.017
pubmed: 23369941
pmcid: 4104687
Brown WE, Koh CE, Badgery-Parker T, Solomon MJ (2017) Validation of MRI and surgical decision making to predict a complete resection in pelvic exenteration for recurrent rectal cancer. Dis Colon Rectum 60:144–151
doi: 10.1097/DCR.0000000000000766
pubmed: 28059910
Pan G, Shirkhoda A (1987) Pelvic exenteration: role of CT in follow-up. Radiology 164:665–670
doi: 10.1148/radiology.164.3.3615864
pubmed: 3615864
Kubik-Huch RA, Weston M, Nougaret S et al (2018) European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of leiomyomas. Eur Radiol 28:3125–3137
doi: 10.1007/s00330-017-5157-5
pubmed: 29492599
pmcid: 6028852
Maciel C, Bharwani N, Kubik-Huch RA et al (2020) MRI of female genital tract congenital anomalies: European Society of Urogenital Radiology (ESUR) guidelines. Eur Radiol 30:4272–4283
doi: 10.1007/s00330-020-06750-8
pubmed: 32221681
pmcid: 7338830
Manganaro L, Lakhman Y, Bharwani N et al (2021) Staging, recurrence and follow-up of uterine cervical cancer using MRI: updated guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018. Eur Radiol 31:7802–7816
doi: 10.1007/s00330-020-07632-9
pubmed: 33852049
Nikolic O, Sousa FAE, Cunha TM et al (2021) Vulvar cancer staging: guidelines of the European Society of Urogenital Radiology (ESUR). Insights Imaging 12:131
doi: 10.1186/s13244-021-01075-6
pubmed: 34550489
pmcid: 8458511
Nougaret S, Horta M, Sala E et al (2019) Endometrial cancer MRI staging: updated guidelines of the European Society of Urogenital Radiology. Eur Radiol 29:792–805
doi: 10.1007/s00330-018-5515-y
pubmed: 29995239
Sheikh-Sarraf M, Nougaret S, Forstner R, Kubik-Huch RA (2020) Patient preparation and image quality in female pelvic MRI: recommendations revisited. Eur Radiol 30:5374–5383
doi: 10.1007/s00330-020-06869-8
pubmed: 32356160
Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247
doi: 10.1016/j.ejca.2008.10.026
pubmed: 19097774
Chandramohan A, Siddiqi UM, Mittal R et al (2020) Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer. Eur J Radiol Open 7:100223
doi: 10.1016/j.ejro.2020.100223
pubmed: 32140502
pmcid: 7044654
Curvo-Semedo L, Lambregts DM, Maas M et al (2011) Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy-conventional MR volumetry versus diffusion-weighted MR imaging. Radiology 260:734–743
doi: 10.1148/radiol.11102467
pubmed: 21673229
Lambregts DMJ, Delli Pizzi A, Lahaye MJ et al (2018) A pattern-based approach combining tumor morphology on MRI with distinct signal patterns on diffusion-weighted imaging to assess response of rectal tumors after chemoradiotherapy. Dis Colon Rectum 61:328–337
doi: 10.1097/DCR.0000000000000915
pubmed: 29369900